Arkema SA (OTCMKTS:ARKAY – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totaling 1,065 shares, a decline of 16.9% from the December 31st total of 1,282 shares. Based on an average daily volume of 13,698 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are sold short. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 13,698 shares, the days-to-cover ratio is presently 0.1 days.
Analyst Ratings Changes
A number of research analysts have recently commented on the stock. Barclays lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 11th. Zacks Research lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 6th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Arkema from a “buy” rating to a “hold” rating in a research report on Monday, November 24th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.
View Our Latest Analysis on Arkema
Arkema Trading Down 2.8%
Arkema (OTCMKTS:ARKAY – Get Free Report) last released its quarterly earnings results on Friday, November 7th. The basic materials company reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.98 by $0.21. Arkema had a return on equity of 5.15% and a net margin of 1.55%.The firm had revenue of $2.52 billion for the quarter, compared to analyst estimates of $2.50 billion. On average, analysts forecast that Arkema will post 8.36 earnings per share for the current fiscal year.
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Further Reading
- Five stocks we like better than Arkema
- Trump just signed it
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- Buy this Gold Stock Before May 2026
- This is the Exact Moment the AI Boom Will End
- GOLD ALERT
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
